BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28351504)

  • 1. Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.
    Gietelink L; Wouters MWJM; Marijnen CAM; van Groningen J; van Leersum N; Beets-Tan RGH; Tollenaar RAEM; Tanis PJ;
    Eur J Surg Oncol; 2017 Jul; 43(7):1297-1303. PubMed ID: 28351504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating national practice of preoperative radiotherapy for rectal cancer based on clinical auditing.
    van Leersum NJ; Snijders HS; Wouters MW; Henneman D; Marijnen CA; Rutten HR; Tollenaar RA; Tanis PJ;
    Eur J Surg Oncol; 2013 Sep; 39(9):1000-6. PubMed ID: 23816270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide analysis of hospital variation in preoperative radiotherapy use for rectal cancer following guideline revision.
    Detering R; de Neree Tot Babberich MPM; Bos ACRK; Dekker JWT; Wouters MWJM; Bemelman WA; Beets-Tan RGH; Marijnen CAM; Hompes R; Tanis PJ;
    Eur J Surg Oncol; 2020 Mar; 46(3):486-494. PubMed ID: 31882252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based guidelines for selective neoadjuvant treatment in rectal cancer: Does MRI adequately predict the indication for radiotherapy in daily practice in a large teaching hospital.
    Tersteeg JJC; Crolla RMPH; Gobardhan PD; Kint PAM; Niers-Stobbe I; Boonman-de Winter L; Arnold DE; Rozema T; Schreinemakers JMJ
    Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13190. PubMed ID: 31863608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MRI for staging of rectal cancer.
    Jhaveri KS; Sadaf A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):469-81. PubMed ID: 19374600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early local recurrence and one-year mortality of rectal cancer after restricting the neoadjuvant therapy regime.
    Tersteeg JJC; van Esch LM; Gobardhan PD; Kint PAM; Rozema T; Crolla RMPH; Schreinemakers JMJ
    Eur J Surg Oncol; 2019 Apr; 45(4):597-605. PubMed ID: 30583821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI cT1-2 rectal cancer staging accuracy: a population-based study.
    Detering R; van Oostendorp SE; Meyer VM; van Dieren S; Bos ACRK; Dekker JWT; Reerink O; van Waesberghe JHTM; Marijnen CAM; Moons LMG; Beets-Tan RGH; Hompes R; van Westreenen HL; Tanis PJ; Tuynman JB;
    Br J Surg; 2020 Sep; 107(10):1372-1382. PubMed ID: 32297326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
    Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
    Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer].
    Rödel C; Sauer R; Fietkau R
    Strahlenther Onkol; 2009 Aug; 185(8):488-92. PubMed ID: 19652930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
    Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
    Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
    Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
    J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer.
    Akasu T; Iinuma G; Takawa M; Yamamoto S; Muramatsu Y; Moriyama N
    Ann Surg Oncol; 2009 Oct; 16(10):2787-94. PubMed ID: 19618244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
    Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
    Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current practice in preoperative therapy and surgical management of locally advanced rectal cancer: a bi-national survey.
    Ooi K; Frizelle F; Ong E; Faragher I
    Colorectal Dis; 2012 Jul; 14(7):814-20. PubMed ID: 21899709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
    Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
    World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients.
    Radu C; Norrlid O; Brændengen M; Hansson K; Isacsson U; Glimelius B
    Acta Oncol; 2013 Apr; 52(3):528-37. PubMed ID: 23113591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.
    Manchon-Walsh P; Aliste L; Espinàs JA; Prades J; Guarga A; Balart J; Biondo S; Castells A; Sanjuan X; Tabernero J; Borras JM;
    Eur J Surg Oncol; 2016 Dec; 42(12):1873-1880. PubMed ID: 27624916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance in rectal cancer treatment.
    van de Velde CJ; van den Broek CB
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.